跳至主要内容
临床试验/JPRN-UMIN000007162
JPRN-UMIN000007162已完成未知

Pharmacodynamics(PD) study of Arbekacin Sulfate in Epithelial Lining Fluid (ELF), an open-label study. - PD study of Arbekacin Sulfate in ELF

Keio University Hospital0 个研究点目标入组 10 人开始时间: 2012年1月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of hypersensitivity caused by aminoglycoside antibiotics or bacitracin. 2) One who has family or patient's history of hearing loss caused by aminoglycoside antibiotics. One who has hearing loss caused by any other reasons. 3)In medication. 4)Creatinine clearance and less than 30mL/min. 5)Smorker. 6)Any other participants whose condition is inappropriate for the evaluation of this clinical study, judged by the investigator.

研究者

相似试验